Predictors of Treatment Response to Electroconvulsive Therapy in Schizophrenia—A Nationwide Registry-Based Study

Up to 30% of patients with schizophrenia respond insufficiently to antipsychotic drugs. Electroconvulsive therapy (ECT) has been reported to effectively augment the effects of antipsychotics in som ...

[1]  M. Neovius,et al.  The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research , 2019, European Journal of Epidemiology.

[2]  C. Correll,et al.  ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials. , 2018, Journal of psychiatric research.

[3]  N. Youssef,et al.  When All Else Fails: The Use of Electroconvulsive Therapy for Conditions Other than Major Depressive Episode. , 2018, Psychiatric Clinics of North America.

[4]  M. Olfson,et al.  Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies , 2018, Schizophrenia bulletin.

[5]  M. Broder,et al.  Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder , 2018, Journal of medical economics.

[6]  M. Landén,et al.  Rehospitalization and suicide following electroconvulsive therapy for bipolar depression-A population-based register study. , 2018, Journal of affective disorders.

[7]  T. Vos,et al.  Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .

[8]  A. Sartorius,et al.  Alcohol Use Disorder as a Possible Predictor of Electroconvulsive Therapy Response , 2017, The journal of ECT.

[9]  D. Blumberger,et al.  Clinical Effectiveness and Cognitive Impact of Electroconvulsive Therapy for Schizophrenia: A Large Retrospective Study. , 2017, The Journal of clinical psychiatry.

[10]  N. Hazari,et al.  Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study , 2017, Psychiatry Research.

[11]  B. Wettermark,et al.  The First Decade with the Swedish Prescribed Drug Register – A Systematic Review of the Output in the Scientific Literature , 2016, Basic & clinical pharmacology & toxicology.

[12]  G. Ungvari,et al.  Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials , 2016, PloS one.

[13]  M. Landén,et al.  Electroconvulsive Therapy in Sweden 2013 , 2015, The journal of ECT.

[14]  Philip Rotella,et al.  An evaluation of variation in published estimates of schizophrenia prevalence from 1990─2013: a systematic literature review , 2015, BMC Psychiatry.

[15]  N. Hazari,et al.  Relationship of obsessive compulsive symptoms/disorder with clozapine: A retrospective study from a multispeciality tertiary care centre. , 2015, Asian journal of psychiatry.

[16]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation , 2015, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[17]  A. Pawełczyk,et al.  Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms , 2014, Psychiatry Research.

[18]  C. Correll,et al.  Clinical predictors of therapeutic response to antipsychotics in schizophrenia , 2014, Dialogues in clinical neuroscience.

[19]  Lori Moss,et al.  Does Comorbid Alcohol and Substance Abuse Affect Electroconvulsive Therapy Outcome in the Treatment of Mood Disorders? , 2014, The journal of ECT.

[20]  S. Leucht.  Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application. , 2014, The Journal of clinical psychiatry.

[21]  M. Landén,et al.  The societal cost of schizophrenia in Sweden. , 2013, The journal of mental health policy and economics.

[22]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[23]  P. Buckley,et al.  Psychiatric comorbidities and schizophrenia. , 2009, Schizophrenia bulletin.

[24]  H. Sackeim,et al.  Electroconvulsive Therapy in Treatment-Resistant Schizophrenia: Prediction of Response and the Nature of Symptomatic Improvement , 2009, European Psychiatry.

[25]  A. Khalilian,et al.  Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients. , 2007, Pakistan journal of biological sciences : PJBS.

[26]  R. Makanjuola,et al.  A controlled trial of modified electroconvulsive therapy in schizophrenia in a Nigerian teaching hospital. , 2004, West African journal of medicine.

[27]  David J Torgerson,et al.  Effect of regression to the mean on decision making in health care , 2003, BMJ : British Medical Journal.

[28]  W. Chanpattana.  The use of the stabilization period in ECT research in schizophrenia: I. A pilot study. , 1999, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[29]  C. Andrade,et al.  An exploratory evaluation of ECT in haloperidol-treated DSM-IIIR schizophreniform disorder. , 1994, Convulsive therapy.

[30]  D. Goldberg,et al.  A Study of Factors Associated with Response to Electroconvulsive Therapy in Patients with Schizophrenic Symptoms , 1989, British Journal of Psychiatry.

[31]  L. Joseph,et al.  Characteristics of Schizophrenic Patients and the Outcome of Fluphenazine and of Electroconvulsive Treatments* , 1987, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[32]  P. Kulhara,et al.  The Efficacy of Electroconvulsive Therapy in the Treatment of Schizophrenia , 1987, British Journal of Psychiatry.

[33]  C. McDonald,et al.  Leicester ECT Trial: Results in Schizophrenia , 1985, British Journal of Psychiatry.

[34]  H. Sauer,et al.  First Rank Symptoms as Predictors of ECT Response in Schizophrenia , 1983, British Journal of Psychiatry.

[35]  J. Lieberman,et al.  Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials , 2004 .

[36]  Baljit Singh,et al.  Efficacy of Electroconvulsive Therapy in Treatment Resistant Schizophreinia : A double-blind study , 2003, Indian journal of psychiatry.

[37]  Julie Kreyenbuhl,et al.  Practice guideline for the treatment of patients with schizophrenia , 1997 .

[38]  H. Meltzer,et al.  Treatment-resistant schizophrenia--the role of clozapine. , 1997, Current medical research and opinion.

[39]  H. Meltzer.  Treatment of the neuroleptic-nonresponsive schizophrenic patient. , 1992, Schizophrenia bulletin.